Fny Investment Advisers, LLC Guardant Health, Inc. Transaction History

Fny Investment Advisers, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 12, 2023	BUY	$22.92 - $33.76 $825 - $1,215	36 Added 2.01%	1,830 $42,000
Q4 2022 Jan 10, 2023	BUY	$25.44 - $59.78 $45,639 - $107,245	1,794 New	1,794 $48,000
Q2 2022 Jul 12, 2022	SELL	$28.82 - $77.35 $4,380 - $11,757	-152 Closed	0 $0
Q1 2022 Apr 25, 2022	BUY	$48.25 - $100.49 $7,334 - $15,274	152 New	152 $10,000
Q1 2020 Apr 09, 2020	SELL	$59.04 - $88.81 $158,404 - $238,277	-2,683 Closed	0 $0
Q4 2019 Jan 10, 2020	BUY	$59.49 - $82.78 $103,096 - $143,457	1,733 Added 182.42%	2,683 $209,000
Q2 2019 Jul 24, 2019	BUY	$63.94 - $91.11 $60,295 - $85,916	943 Added 13471.43%	950 $82,000
Q1 2019 Apr 17, 2019	BUY	$34.3 - $97.98 $240 - $685	7 New	7 $0

323

127M

844K

2.38M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.34B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.